LENVIMA is a prescription medicine that is used to treat certain kinds of cancer.

  • LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing.
  • LENVIMA is used to treat adults with a type of kidney cancer called advanced renal cell carcinoma (RCC):
    • along with the medicine pembrolizumab as your first treatment when your kidney cancer has spread or cannot be removed by surgery.
    • along with the medicine everolimus after one course of treatment with another anti-cancer medicine.
  • LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery.
  • LENVIMA is used along with another medicine called pembrolizumab to treat advanced endometrial carcinoma (EC), a type of uterine cancer:
    • when a laboratory test shows that your tumor is mismatch repair proficient (pMMR) or not microsatellite instability high (MSI-H), and
    • you have received anti-cancer treatment, and it is no longer working, and
    • your cancer cannot be cured by surgery or radiation

It is not known if LENVIMA is safe and effective in children.

View full indication
Important Safety Information & Full Prescribing Information
LENVIMA

Back

Select cancer type

Learn About Clinical Trial Results for LENVIMA® (lenvatinib)Learn About Clinical Trial Results for LENVIMA® (lenvatinib)